Introducing MIMS Disperse & Crush Guide — supporting safer oral medicine administration across Australian healthcare.
MIMS Australia is proud to present the 2025 MIMS / College Intern of the Year during the Australian Pharmacy Professional Conference held March 12 to 14 at Goldcoast, Australia.
MIMS is pleased to announce that Heidi Health is the newest MIMS ANZ Integrated partner. Through this collaboration, MIMS clinical content will be available directly within Heidi Evidence across the ANZ region – a clinical grade research tool that gives clinicians independent, unlimited answers from trusted sources.
The Philippine Academy of Family Physicians Inc. (PAFP) and MIMS Philippines solidified their partnership by signing the Memorandum of Agreement (MOA) aimed at developing collaborative content for MIMS Doctor, a quarterly multidisciplinary magazine for the Philippine medical community.
We are excited to announce the launch of a new partnership between MIMS Australia and the Australian Dental Association (ADA) commencing in 2026.
2026 ushers a new chapter for MIMS as the company welcomes Sohil Goswami as its new CEO.
SYDNEY, August 2, 2025 – MIMS Australia is proud to sponsor the PSA MIMS Intern Pharmacist of the Year award given at the Pharmaceutical Society of Australia (PSA) National Conference held in Sydney on August 1-3, 2025.
VIETNAM, July 25, 2025 – MIMS Vietnam and Hoan My Academy have entered a strategic partnership to co-develop, connect and disseminate evidence?based medical education content for healthcare professionals across the Hoan My network.
SINGAPORE, April 2, 2025 – MIMS Clinical Decision Solutions (CDS)–Asia Strategic Unit is proud to unveil its new brand identity with a new logo and tagline.
SYDNEY, March 5, 2025 – MIMS Australia recently held the MIMS Advisory Board meeting in Sydney on February 27. Attended by nine (9) honorary Board Members and internal teams including Editorial, Product, Business, and Operations, the meeting provided an invaluable opportunity to highlight MIMS’s latest product offering and discuss the future roadmap for enhancing and improving clinical workflows for all users.
KUALA LUMPUR, FEBRUARY 12, 2025 – Malaysians looking for credible health information will have a new way to access it—right from the Lumi News app. MIMS Malaysia has partnered with Lumi News to feature HealthToday, Malaysia’s premier health resource, on the platform, bringing expert-backed health articles, wellness tips, and medical insights directly to Lumi News users.
KUALA LUMPUR, November 7, 2024 — MIMS Malaysia is pleased to announce a strategic partnership with Newswav, a leading trilingual news and content aggregator.
MIMS’s Centre of Excellence (COE) office in the Philippines has successfully renewed its ISO certification (for listing processes) in July 2024. This outstanding achievement underscores the company’s steadfast commitment to excellence and continuous improvement across the MIMS Group.
A Special Message from Robert Best, Executive Vice President, CDS Pacific “On behalf of the CDS Pacific team, I am delighted to announce the launch of MIMS Drugs4dent® for the Australian market – this is a new, medicines resource to target dental practitioners and Oral Health specialists which was developed in conjunction with leading Oral Health Australian academics from the University of Melbourne, Dr Leanne Teoh and Professor Michael McCullough.
We had a fantastic turnout and engagement at our mid-year update held online on June 26th! More than 300 team members of the MedComms and Marketing Platform business units from across Asia gathered virtually to listen and learn from one another.
KUALA LUMPUR, June 9, 2024 — Congratulations to MIMS Malaysia for having been chosen as Finalist in two categories at the Employee Experience Awards Malaysia 2024.
A Special Message from Cassie Humphreys, President, Medical Marketing: Dear Colleagues, Clients, and Partners, I am thrilled to announce that after several years supporting international clients in the Middle East, we have officially established a local team to bring our scientific strategy and medical consultancy expertise to a wider range of clients across the region.
Effective 1 April 2024, MIMS acquires 100% of the shares of SMS Philippines Healthcare Solutions Inc from SMS Asia. This acquisition was part of an internal reorganization within the SMS Group, as both MIMS and SMS Asia are subsidiaries of the SMS Group, rather than an external acquisition.
SINGAPORE, May 24, 2023 – “Pioneering spirit” since 1963 continues with new markets, new app/website, new insights and more for 2023 and beyond
MIMS Pte Ltd has recently acquired two German companies in the global career business to further expand its recruitment business and to address the growing demand for medical and elderly care professionals in Germany.
SINGAPORE, September 22, 2022 – MIMS, the largest multi-channel provider of drug information, medical communications, events management and marketing services in the Asia Pacific (APAC) region – today announced a strategic collaboration with Syneos Health Communications – the portfolio of Syneos Health® agencies designed
Singapore – MIMS, the region’s leading healthcare data and medical knowledge provider, is proud to announce that MIMS has successfully collaborated with Singapore’s Ministry of Health (MOH) on the editorial contents for the National Drug Formulary (NDF) website.
MIMS, a global provider of medical information, education and knowledge services, is one of the exhibitors at the upcoming SNOMED CT Expo 2021 Virtual Event, and a sponsor of the Asia Pacific Keynote Session.
SINGAPORE, April 12, 2021 – MIMS collaborated with Singapore Management University (SMU-X), School of Economics, as part of SMU – X’s initiative to combine academic rigour with experiential learning. The two organizations jointly worked on topics around the impact of COVID-19 on Pharmaceutical Supply Chains, Preventive Healthcare and the Rise of Telemedicine in South East Asia.
JAKARTA, March 19, 2021 – We are excited to share that MIMS Pte Ltd is the exclusive partner of the Center for Indonesian Medical Students’ Activities (CIMSA) for the first-ever virtual Health Hackathon Competition. The topic is “Building Resilient Healthcare Systems During and After Pandemic.”
Webcast sees the participation of 3,600 healthcare professionals from across Asia Pacific
MIMS Pte Ltd recently launched a dedicated webpage containing the latest updates for COVID-19 which is available at https://enews.mims.com/covid-19/index.html
As the pandemic continues to spread globally, our employees and valued customers remain a priority.
Earlier this month, our colleagues in MIMS (Singapore) began the collection of food items to support The Food Bank Singapore. Some of these items donated include rice, canned food, and other pantry items.
MIMS Group, Asia’s largest multi-channel provider of drug information, medical communications, events management and marketing services, and Ashfield Healthcare Communications KK, announced they have combined operations in Japan. The newly established organisation will be operating as MIMS Japan Co. Ltd.
MIMS, Asia’s largest multi-channel provider of drug information, medical communications, events management and marketing services, and Ashfield Healthcare Communications, are pleased to announce the creation of a new global alliance.
MIMS has clinched three awards, including the Front Cover of the Year (Trade) and the Designer of the Year, at the Media Publishers Association Singapore (MPAS) Awards 2018 held recently at One Farrer Hotel.
The BlocPartners, the leading global independent health-creative agency network, and MIMS, Asia’s largest multi-channel provider of drug information, medical communications, events management and marketing services, announced they have formalized a strategic partnership.
MIMS Philippines Regional Editorial Office (PH REO), MediMarketing Inc., has been recommended for the Certification of ISO 9001:2015 after clearing the Certification Stage 2 Audit conducted by TÜV NORD, a well-known global company accepted widely by relevant accreditation bodies in management system certification. This is an important milestone for MIMS as one of the leading healthcare data, medical knowledge and drug information providers in the Asia Pacific.
MIMS, the region’s leading healthcare data & medical knowledge provider, has partnered with Assurance Technology to improve patient safety with the integration of optimised medication features into Clinic Assist software.
MIMS Australia is proud to be the lead sponsor of the joint Pharmaceutical Society of Australia (PSA) – MIMS Intern Pharmacist of the Year Award 2018.
Malaysia-based MIMS Career Sdn. Bhd. (MIMS Career), subsidiary of MIMS Group, is pleased to announce the acquisition of 100% share capital of Melorita Consultants Sdn. Bhd, Malaysia’s pioneering healthcare recruitment agency.
The process of setting up and operating a medical practice of any nature can be increasingly challenging with respect to clinic operations and administration as well as business efficiency. MIMS, a veteran in the Asian healthcare industry has addressed these challenges with the launch of its latest practice management solution – MIMS Clinic Information System (CIS).
MIMS, the leading provider of drug information and services connecting healthcare communities has launched a new career portal dedicated to healthcare professionals who are looking for their next career opportunity within the healthcare community.
MIMS, a leading provider of drug information and medical education for healthcare professionals, is expanding its relationship with Makati Medical Center (MakatiMed) to further its mission of enhancing medication adherence and safety outcomes.